Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 2
2012 1
2013 1
2014 6
2015 3
2016 2
2018 2
2019 2
2020 1
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators. Dimopoulos MA, et al. Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26671818 Free article. Clinical Trial.
Comparaison du rapport coût-efficacité de la toxine botulinique de type A associé aux meilleurs soins de support vs les meilleurs soins de support seuls dans le traitement de l'hyperactivité vésicale idiopathique avec incontinence urinaire chez les patients réfractaires au traitement anti-cholinergique en France.
Turner L, Velard ME, Loveman C, Khalaf K, Roze S, Pignata M, Stanisic S, Lister J, Ruffion A. Turner L, et al. Among authors: stanisic s. Prog Urol. 2014 Nov;24(13):799-800. doi: 10.1016/j.purol.2014.08.040. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461566 French. No abstract available.
A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey.
Hashemi F, Hoepner L, Hamidinejad FS, Haluza D, Afrashteh S, Abbasi A, Omeragić E, Imamović B, Rasheed NA, Taher TMJ, Kurniasari F, Wazqar DY, Apalı ÖC, Yildirim AD, Zhao B, Kalikyan Z, Guo C, Valbuena AC, Mititelu M, Pando CM, Saridi M, Toska A, Cuba ML, Kwadzokpui PK, Tadele N, Nasibova T, Harsch S, Munkh-Erdene L, Menawi W, Evangelou E, Dimova A, Marinov D, Dimitrova T, Shalimova A, Fouly H, Suraya A, da Silva Faquim JP, Oumayma B, Annunziato MA, Lalo R, Papastavrou E, Ade AD, Caminada S, Stojkov S, Narvaez CG, Mudau LS, Rassas I, Michel D, Kaynar NS, Iqbal S, Elshwekh H, Hossain I, Al-Fayyadh S, Sydorchuk A, Alnusairat DMH, Abdullahi AM, Iqbal N, Pandey A, Gómez-Gómez B, Akyildiz AG, Morosan E, Dwarica D, Dorj G, Hasan SY, Al-Shdayfat NM, Knezevic B, Valladares W, Severi C, Fuentes SC, Augusto S, Sidorova E, Moelyaningrum AD, Alawad T, Khalid A, Elehamer NMK, Mihaylova A, Tsigengagel O, Menouni A, Wojtecka A, Hod R, Idayat YB, Othman K, Harfouch RM, Paunov T, Omar M, Benderli NC, Nurika G, Amjad S, Elnoamany S, Elesrigy F, Shaban MM, Acevedo-López D, Kartashova M, Khalaf A, Jaafar SA, Kadhim TA, Hweissa NA, Teng Y, Mohammed FE, Sasikumar T, Hikaambo CN, Kharat A, Lyamtseva U, … See abstract for full author list ➔ Hashemi F, et al. Among authors: stanisic s. Environ Sci Pollut Res Int. 2023 Jun;30(28):72368-72388. doi: 10.1007/s11356-023-27197-6. Epub 2023 May 11. Environ Sci Pollut Res Int. 2023. PMID: 37166731 Free PMC article.
The role of melatonin in preventing amiodarone-induced rat liver damage.
Petrović D, Ilić MD, Simonović D, Stojanović M, Stanković M, Stanišić S, Stojanović S, Arsić N, Sokolović DT. Petrović D, et al. Among authors: stanisic s. Can J Physiol Pharmacol. 2023 Dec 11. doi: 10.1139/cjpp-2023-0253. Online ahead of print. Can J Physiol Pharmacol. 2023. PMID: 38079620
22 results